Treace Medical Concepts, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $8.00K, a 93.10% decline year-over-year.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $91.00K, a 23.53% decline year-over-year.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $241.00K, a 2912.50% increase year-over-year.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $116.00K, a 62.70% decline year-over-year.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $546.00K, a 27.57% increase from fiscal 2024.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $428.00K, a 77.10% decline from fiscal 2023.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.87M, a 14.54% decline from fiscal 2022.
- Treace Medical Concepts, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $2.19M, a 19.51% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $8.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $91.00K 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $546.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | $241.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $116.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $119.00K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $428.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $8.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $311.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $52.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $1.87M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $159.00K 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $1.18M 10-Q · filed 2024-11-05 | |
| 2023-03-31 | $352.00K 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $2.19M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $353.00K 10-Q · filed 2023-11-09 | $2.92M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $165.00K 10-Q · filed 2023-11-09 | $2.60M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.37M 10-Q · filed 2023-11-09 | $2.63M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.83M 10-K · filed 2024-02-27 |
| 2021-09-30 | $41.00K 10-Q · filed 2022-11-09 | $1.13M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $193.00K 10-Q · filed 2022-11-09 | $1.09M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $570.00K 10-Q · filed 2022-11-09 | $893.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $364.00K 10-K · filed 2023-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2020-03-31 | $41.00K 10-Q · filed 2021-05-25 | |
| 2019-12-31 | $68.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |